Zimmer Biomet Holdings, Inc. earnings per share and revenue
On 05 de nov. de 2025, ZBH reported earnings of 1.90 USD per share (EPS) for Q3 25, beating the estimate of 1.88 USD, resulting in a 0.73% surprise. Revenue reached 2.00 bilhão, compared to an expected 2.02 bilhão, with a -1.15% difference. The market reacted with a -15.15% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 27 analistas forecast an EPS of 2.41 USD, with revenue projected to reach 2.25 bilhão USD, implying an aumentar of 26.84% EPS, and aumentar of 12.58% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
FAQ
What were Zimmer Biomet Holdings, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zimmer Biomet Holdings, Inc. reported EPS of $1.90, beating estimates by 0.73%, and revenue of $2.00B, -1.15% below expectations.
How did the market react to Zimmer Biomet Holdings, Inc.'s Q3 2025 earnings?
The stock price moved down -15.15%, changed from $103.18 before the earnings release to $87.55 the day after.
When is Zimmer Biomet Holdings, Inc. expected to report next?
The next earning report is scheduled for 05 de fev. de 2026.
What are the forecasts for Zimmer Biomet Holdings, Inc.'s next earnings report?
Based on 27
analistas, Zimmer Biomet Holdings, Inc. is expected to report EPS of $2.41 and revenue of $2.25B for Q4 2025.